About Space OAR™

About SpaceOAR™
Hydrogel

A little space before prostate cancer radiation can make a BIG difference after.

At median 3 years, patients in the US pivotal trial who underwent prostate cancer radiation therapy with SpaceOAR Hydrogel experienced fewer clinically significant declines in bowel, urinary and sexual function than patients without SpaceOAR Hydrogel.1-2

FEWER SEXUAL COMPLICATIONS

SpaceOAR Hydrogel patients who had erections sufficient for intercourse at baseline were 67% more likely to retain erectile function at 3 years.1

FEWER URINARY COMPLICATIONS

The use of SpaceOAR Hydrogel reduced the likelihood of either a MID or more serious changes in urinary QOL by >60%.2

bowel

FEWER BOWEL COMPLICATIONS

At 3 years, grade 1 rectal toxicity was decreased by 75% in patients treated with SpaceOAR Hydrogel versus the control group.2

Real Patients, Real Stories

Hear from prostate cancer survivors who have benefited from SpaceOAR Hydrogel as well as from the physicians who provide it to their patients.

More Than 280,000 Patients Worldwide Have Been Treated with SpaceOAR Hydrogel

More Than 280,000 Patients Worldwide Have Received SpaceOAR Hydrogel.*3

Download a discussion guide to help you talk to your doctor about whether SpaceOAR Hydrogel is right for you.

Download a Discussion Guide

Frequently Asked Questions

Why should I have SpaceOAR Hydrogel?

The rectum and prostate are in close proximity, which means during radiation therapy for prostate cancer, there can be unintended damage to the rectum, leading to issues with bowel function or other side effects.4 SpaceOAR Hydrogel is a polyethylene glycol (PEG) based absorbable hydrogel that temporarily creates space between the prostate and rectum, designed to reduce radiation dose to the rectum and may help minimise the side effects of radiation therapy.3

 

What is SpaceOAR Hydrogel made of?

SpaceOAR Hydrogel is a CE marked implant made mostly of water (90%) and PEG (7%) that, when combined, form a soft gel-like synthetic material.3 PEG is a material commonly used in other medical products.3 You should discuss any known allergies you may have to the SpaceOAR hydrogel with your doctor.

What is the procedure like and how long will it stay in my body?

SpaceOAR Hydrogel is injected as a liquid through a needle inserted between the rectum and the prostate. It can be implanted via a local anesthetic that will numb the injection area or under general anesthesia that will put a patient to sleep during the procedure. SpaceOAR Hydrogel stays in place for about 3 months and is naturally absorbed into the body and removed through urine in about 6 months.3

Watch a video animation

What are the risks?

SpaceOAR Hydrogel contains PEG. As with any medical treatment, there are some risks involved with the use of SpaceOAR Hydrogel. Potential complications associated with SpaceOAR Hydrogel include, but are not limited to: pain associated with injection, pain or discomfort from the hydrogel, site inflammation, infection (including abscess), inability to urinate, urgent need to urinate, constipation, rectal muscle spasm, damage to lining of rectum, ulcers, fistula (a hole between rectum and bladder, urethra, or skin below the scrotum), perforation (hole in prostate, bladder, urethra, recturm), necrosis (dead tissue), allergic reaction (local reaction or more severe reaction, such as anaphylaxis), embolism (blood vessel blockage is possible and may happen outside of the pelvis, potentially impacting vital organs or legs), fainting, and bleeding. If one or more of these complications occur, you may need medical treatment or surgery. Please talk to your doctor about the risks and benefits related to using SpaceOAR Hydrogel.

Find a doctor who offers SpaceOAR Hydrogel near you.

Find a doctor who offers SpaceOAR Hydrogel near you.

You will be redirected to a map view showing you the nearest hospital to your location.

Find a doctor

How to Get Started with SpaceOAR Hydrogel

If you need help or have questions along the way, contact us.

Why SpaceOAR Hydrogel?

Treatment Options


Find a doctor who offers SpaceOAR Hydrogel

Download Our Patient Brochure

Download a Patient Information Brochure

Download Our Patient Brochure

Prostate Cancer Patient Information

SpaceOAR Hydrogel is intended to temporarily move the rectal wall away from the prostate during the course of radiotherapy treatment for prostate cancer, and in creating this space it is the intent of SpaceOAR Hydrogel to reduce the radiation dose affecting the rectum.SpaceOAR Hydrogel contains polyethylene glycol (PEG). As with any medical treatment, there are some risks involved with the use of SpaceOAR Hydrogel. Potential complications associated with SpaceOAR Hydrogel include, but are not limited to: pain associated with injection, pain or discomfort from the hydrogel, site inflammation, infection (including abscess), inability to urinate, urgent need to urinate, constipation, rectal muscle spasm, damage to lining of rectum, ulcers, fistula (a holebetween rectum and bladder, urethra, or skin below the scrotum), perforation (hole in prostate, bladder, urethra, rectum), necrosis (dead tissue), allergic reaction (local reaction or more severe reaction, such as anaphylaxis), embolism (blood vessel blockage is possible and may happen outside of the pelvis, potentially impacting vital organs or legs), fainting, and bleeding. Please talk to your doctor about the risks and benefits related to using SpaceOAR Hydrogel. If one or more of these complications occur, you may need medical treatment or surgery. URO-1288805-AA APR 2022

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device. Information for use only in countries with applicable health authority registrations. This material not intended for use in France. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. Please check availability with your local sales representative or customer service.

 

References

* Number of patients is based on units shipped and a BSC proprietary algorithm

  1. Hamstra DA, Mariados N, Sylvester J, et al. Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3 trial. Pract Radiat Oncol. 2018;8(1):e7‐e15.
  2. Hamstra DA, Mariados N, Sylvester J, et al. Continued benefit to rectal separation for prostate radiation therapy: Final results of a phase III trial. Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):976-85.
  3. Data on file. 
  4. Radiation Therapy for Prostate Cancer. American Cancer Society. http://www.cancer.org/cancer/prostate-cancer/treating/radiation-therapy.html. Accessed April 25, 2023.